The FDA isn’t issuing one-off wearable clearances any more - it’s building a regulatory architecture for continuous diagnostic surveillance. Cardiac, metabolic, neurodx, and RPM all moving in parallel. Medicine needs to catch up fast. #DigitalHealth #FDAclearance #ClinicalAI
Jay Pandit
@JayPandit
Director of Digital Medicine, Scripps Research, NU Cardiology, Physician Entrepreneur, Cancer Survivor, Story Banker and Life Long Learner. Views are my own.
262 Following 370 Followers 119 Posts
Latest posts 5
Can a weight loss and diabetes drug treat long COVID? – San Diego Union-Tribune sandiegouniontribune.com/2025/10/30/can…
Acute care at home has all the ingredients to improve health care outcomes and costs and is the ideal place to test the impact of multimodal inpatient and outpatient health data streams. Let’s do the trials to show this!
nature.com/articles/s4174…
nature.com/articles/s4174…
RIP Pele!! To the King, who made millions fall in love with Joga Bonito!! #Pele #JogaBonito
First report of our prospective paxlovid rebound study showing rebound of Covid sx more than previously reported, in both treated and untreated cohorts. More studies needed to understand this peculiar phenomenon, to clear myths causing underprescription.
Our prospective Paxlovid rebound study with controls preprint is postedView quoted post on X
By symptoms: ~12% rebound (19% Pax vs 7% controls)
By positive testing: ~5% rebound (14% Pax vs 9% controls)
Much lower than many estimates
medrxiv.org/content/10.110… by @JayPandit @michaelmina_lab @ScrippsRTI